Genus plc (LON:GNS) Receives Consensus Recommendation of “Buy” from Brokerages

Share on StockTwits

Genus plc (LON:GNS) has been given a consensus rating of “Buy” by the seven brokerages that are currently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is GBX 3,082.83 ($40.28).

Several equities analysts have recently issued reports on the company. Liberum Capital lifted their price target on Genus from GBX 2,800 ($36.59) to GBX 3,450 ($45.08) and gave the stock a “buy” rating in a research report on Thursday, November 28th. Peel Hunt reissued a “buy” rating and set a GBX 3,200 ($41.81) price objective on shares of Genus in a research report on Thursday, November 14th. HSBC raised their price objective on shares of Genus from GBX 3,000 ($39.20) to GBX 3,260 ($42.60) and gave the company a “buy” rating in a research note on Wednesday, November 13th. Peel Hunt restated a “buy” rating on shares of Genus in a research note on Thursday. Finally, Jefferies Financial Group initiated coverage on shares of Genus in a report on Friday, November 15th. They issued a “hold” rating and a GBX 3,272 ($42.75) target price for the company.

In related news, insider Lysanne Gray sold 1,298 shares of Genus stock in a transaction dated Monday, September 16th. The stock was sold at an average price of GBX 2,858 ($37.34), for a total value of £37,096.84 ($48,473.59). Also, insider Dan Hartley sold 7,267 shares of the business’s stock in a transaction dated Wednesday, September 18th. The stock was sold at an average price of GBX 2,894 ($37.82), for a total value of £210,306.98 ($274,803.32). Over the last quarter, insiders have sold 22,851 shares of company stock worth $67,205,592.

Shares of LON GNS traded up GBX 36 ($0.47) during trading on Friday, reaching GBX 3,140 ($41.03). The company had a trading volume of 74,848 shares, compared to its average volume of 78,154. Genus has a 12-month low of GBX 2,122 ($27.73) and a 12-month high of GBX 3,224 ($42.13). The stock has a market cap of $2.06 billion and a PE ratio of 263.87. The business’s 50-day moving average is GBX 3,019.56 and its 200 day moving average is GBX 2,772.24. The company has a quick ratio of 1.19, a current ratio of 2.01 and a debt-to-equity ratio of 21.92.

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Article: What is total return in investing?

Analyst Recommendations for Genus (LON:GNS)

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Columbia Banking System  Cut to Hold at Zacks Investment Research
Columbia Banking System Cut to Hold at Zacks Investment Research
Corcept Therapeutics  Raised to “Buy” at BidaskClub
Corcept Therapeutics Raised to “Buy” at BidaskClub
Ascendis Pharma A/S  Given New $148.00 Price Target at Morgan Stanley
Ascendis Pharma A/S Given New $148.00 Price Target at Morgan Stanley
BMC Stock  Lifted to Buy at BidaskClub
BMC Stock Lifted to Buy at BidaskClub
Costco Wholesale  Price Target Raised to $300.00 at Wells Fargo & Co
Costco Wholesale Price Target Raised to $300.00 at Wells Fargo & Co
Cheesecake Factory  Downgraded by Morgan Stanley to “Underweight”
Cheesecake Factory Downgraded by Morgan Stanley to “Underweight”


 
© 2006-2020 Zolmax.